Applying ASCO GU 2024 Data to Clinical Practice in Bladder, RCC Care
Paul V. Viscuse, MD, spotlights key data from the 2024 Genitourinary Cancers Symposium in bladder cancer and renal cell carcinoma.
Source: onclive.com
Bladder Cancer Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bladder Cancer Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bladder Cancer Section Today - Breaking & Trending Today
Pembrolizumab Improves Disease-Free Survival for Muscle-Invasive Urothelial Carcinoma
The late-breaking data at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium included the results of KEYNOTE-123 for locally advanced resectable urothelial carcinoma.
Source: pharmacytimes.com
AMBASSADOR: Adjuvant Pembro Boosts DFS in Urothelial Cancer
Interim findings from the ongoing AMBASSADOR trial revealed a significant DFS benefit with adjuvant pembrolizumab but no overall survival benefit at this point.
Source: medscape.com
Dr Apolo on Adjuvant Pembrolizumab in Muscle-Invasive Urothelial Carcinoma
Andrea B. Apolo, MD, discusses the AMBASSADOR Alliance A031501 trial of adjuvant pembrolizumab in locally advanced/muscle-invasive urothelial carcinoma.
Source: onclive.com
Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer
Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new treatment option.
Source: news-medical.net